Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Join | Sign in
Home>Videos>This Video
  Videos

Return

Strategic Applications of Flow Chemistry within Drug Discovery
Pfizer, Inc.

Despite the significant growth of interest in Flow Chemistry, it is often challenging to integrate this into research programs. Given the fast paced nature of drug discovery, and the growing constraint on resources, it is important to recognize opportunites to utilize Flow Chemistry at times when it can bring the maximum benefit to the program under study. This talk will look at several scenarios where this has been implemented within Pfizer. Firstly, one of the key interests is the opportunity to rapidly expand into novel chemical space, which is important both from a proprietary and pharmacological properties standpoint. Development of robust flow methodologies with a particular focus on library generation offers a unique opportunity to do this. Secondly, one of the most significant advantages of working in Flow is the ability to work with hazardous reagents, and examples of this will also be presented. Finally, expediting compounds as they progress is enabled through use of Flow by simply “scaling out” processes as opposed to “scaling up”. This talk will touch on the interaction between medicinal chemistry and process chemistry, and look at some of the benefits of screening chemistries to make them more amenable to flow with this in mind.

Request more information
Company product page


Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Allergy Drug Inhibits Hepatitis C in Mice
NIH study suggests alternative drug to treat virus.
Saccharin Shows Promise as Cancer Inhibitor
Researchers have found that the artificial sweetener can inhibit cancer cell growth.
Treating Canine Periodontal Disease
The class of compounds, designed to resolve inflammation, has potential to treat chronic disease in animals and humans.
‘Warhead’ Molecule Targets Deadly Bacteria
Boston college chemists target bacterial lipids to label deadly bacteria, spare healthy cells.
Garlic Could Aid Cystic Fibrosis Fight
A chemical in garlic kills bacteria that cause deadly infections in people with cystic fibrosis, University of Edinburgh research shows.
UGA Researchers Discover Potential Treatment for Drug-resistant Tuberculosis
Researchers have developed a new small molecule drug as a treatment against multi-drug resistant tuberculosis.
A Protein's Novel Role In Several Types Of Cancers Discovered
Stanford ChEM-H scientists are helping to develop a novel cancer therapy based on a new finding of a protein that inadvertently promotes cancer growth.
Cancer Treatment with KU Origins Enters Second Clinical Trial
Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.
Grant will Help Develop More Powerful Disinfectants
$200,000 grant awarded to develop the next generation of antibacterial cleansers and disinfectants.
Artificially-intelligent Robot Scientist ‘Eve’ Could Boost Search for New Drugs
Eve, an artificially-intelligent ‘robot scientist’ could make drug discovery faster and much cheaper, say researchers writing in the Royal Society journal Interface.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters